ARNI, LBBB, COVID-19 and various other topics

Código QR

ARNI, LBBB, COVID-19 and various other topics

Guardado en:

Detalles Bibliográficos
Autor principal:	Çetin Erol
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/cbec6e9062b84d6bbbbd3b71f8fe3f17
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
por: Pankaj Jariwala, et al.
Publicado: (2021)

GLP-1, SGLT-2, new devices for interventional cardiologists
por: Çetin Erol
Publicado: (2021)

Studies and Reviews on Central Sleep Apnea, Endovascular Therapy, Robotic Surgery, and the associated Clinical and Genetic Characteristics in Cardiology
por: Çetin Erol
Publicado: (2021)

Ramadan, TURKMI, REALITY HF, and so on…0
por: Çetin Erol
Publicado: (2021)

Carotid artery stenting, new devices and techniques for interventional cardiology and atrial fibrillation
por: Çetin Erol
Publicado: (2021)

Colchicine, fragmented QRS, coronavirus disease 2019, and more
por: Çetin Erol
Publicado: (2021)

Energy drinks, pulmonary hypertension, and many more
por: Çetin Erol
Publicado: (2021)

New impact factor and many new studies
por: Çetin Erol
Publicado: (2021)

Miscellaneous attractive studies
por: Çetin Erol
Publicado: (2021)

New year and our 20th Anniversary, Thomas F. Lüscher, pulmonary hypertension
por: Çetin Erol
Publicado: (2021)

Fragmented QRS is a marker of mortality in patients with severe COVID-19: A retrospective observational study
por: İbrahim Halil Özdemir, et al.
Publicado: (2021)

The effectiveness and tolerability of switching Indian patients from sacubitril/valsartan, ARNI to perindopril in heart failure with reduced ejection fraction. [Efficient study]
por: Pankaj Jariwala, et al.
Publicado: (2021)

Perimyocarditis Following COVID-19 Vaccination
por: Mariana Tinoco, et al.
Publicado: (2021)

COVID-19 Pandemic and Cardiovascular Disease
por: Aniket S Rali, et al.
Publicado: (2020)

Diagnosis of Takotsubo syndrome in the COVID-19 era
por: Kristian Rivera, et al.
Publicado: (2021)

Diagnosis of Takotsubo syndrome in the COVID-19 era
por: Kristian Rivera, et al.
Publicado: (2021)

D-dimer, COVID-19 and Diabetes: A Correspondence
por: Sora Yasri PhD, et al.
Publicado: (2021)

An Evaluation of Cardiology Virtual Care During the COVID-19 Pandemic
por: Kate E. Sanderson, MBA, et al.
Publicado: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021)

Diabetes and mortality in patients with COVID-19: Are we missing the link?
por: Marco Toselli2, et al.
Publicado: (2021)

High-flow Nasal Cannula Oxygenation Revisited in COVID-19
por: Aniket S Rali, et al.
Publicado: (2020)

COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020)

Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
por: Dimitrios A. Vrachatis, et al.
Publicado: (2021)

Takotsubo Syndrome During the COVID-19 Pandemic: State-of-the-Art Review
por: Gassan Moady, MD, et al.
Publicado: (2021)

Daily monitoring of D-dimer allows outcomes prediction in COVID-19
por: David M Smadja, et al.
Publicado: (2021)

Spontaneous, severe, and diffuse coronary vasospasm in a patient with COVID-19
por: Mutlu Çağan Sümerkan, et al.
Publicado: (2021)

Experience of adults with congenital heart disease during the COVID-19 pandemic
por: Mikyla Janzen, et al.
Publicado: (2021)

Thrombosis in COVID-19: We still need to learn a lot
por: Cem Barçın
Publicado: (2021)

Thrombosis, an important piece in the COVID-19 puzzle: From pathophysiology to therapy
por: Elena Bobescu, et al.
Publicado: (2021)

Excess mortality in Greece during 2020: the role of COVID-19 and cardiovascular disease
por: Demosthenes Panagiotakos, et al.
Publicado: (2021)

Rate of COVID-19 Infection in Patients With ST-Segment Elevation Myocardial Infarction
por: Maneesh Sud, MD, et al.
Publicado: (2021)

Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study
por: Marina Cecelja, et al.
Publicado: (2021)

Lockdown, slow down: impact of the COVID-19 pandemic on physical activity—an observational study
por: Joanne Kathryn Taylor, et al.
Publicado: (2021)

Thrombosis After Adenovirus-Vectored COVID-19 Vaccination: A Concern on Underlying Illness
por: Rujittika Mungmunpuntipantip, et al.
Publicado: (2021)

Postoperative Nosocomial COVID-19 Infection in Cardiac Surgery: An Uncommon Event With High Mortality Rate
por: Khalid Ridwan, MD, MSc, et al.
Publicado: (2021)

Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19
por: Priyal Agarwal MD, et al.
Publicado: (2021)

Transcatheter valve-in-valve implantation for sutureless bioprosthetic aortic paravalvular leak in the era of COVID-19
por: Şakir Arslan, et al.
Publicado: (2021)

Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs
por: Thomas A Zelniker, et al.
Publicado: (2019)

The non-infectious effects of COVID-19 were fierce with the weakest: What lessons did we learn?
por: Aline Meza-Ramos, et al.
Publicado: (2021)

Interleukin-6 level is an independent predictor of right ventricular systolic dysfunction in patients hospitalized with COVID-19
por: Mehmet Erdoğan, et al.
Publicado: (2021)